Vaginal oxytetracycline concentrations.
Although tetracycline preparations are widely used in departments of genitourinary medicine, or sexually transmitted diseases clinics, little is known of the concentrations of these preparations in genital secretions. For this reason a microbiological method was used for estimating oxytetracycline concentrations in vaginal secretions. These concentrations varied from 0.6 to 6.5 microgram/ml in 19 women who had had sexual contact with a man with non-specific urethritis and who were taking oxytetracycline dihydrate 250 mg four times daily. They were well in excess of the minimum inhibitory concentration of oxytetracycline (0.2 microgram/ml) for the strains of Chlamydia trachomatis isolated from the patients with positive culture results. Thus, oxytetracycline 250 mg four times daily appears to be a satisfactory regimen for the treatment of chlamydial genital infection in women.
D000293:Adolescent; D000328:Adult; D001681:Biological Assay; D001826:Body Fluids / Q000378:metabolism; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010118:Oxytetracycline / Q000008:administration & dosage / Q000378:metabolism*; D014621:Vagina / Q000378:metabolism* / Q000382:microbiology
D010118:Oxytetracycline